We are Sorry, This Page doesn't Exist
Karyopharm Stock Is Trading Higher After China"s NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings
read more.....»»
Poseida jumps after providing case study on prostate cancer patient
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Janssen"s Erleada Plus, Zytiga Plus Prednisone Combo Treatment Shows Clinical Benefit In Late-Stage Prostate Cancer Study
read more.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
VANCOUVER and HOUSTON, May 7, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX, TSXV:EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpora.....»»
Nymox announces publication of prostate cancer fexapotide trial results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A study found people who have had 10 or more sexual partners may have a higher risk of cancer
Redakie/Shutterstock A new study suggests that people who've had 10 or more sexual partners in their lifetimes have a heightened risk of developing cancer. Certain sexuall.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019
VANCOUVER and HOUSTON, Dec. 19, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX, TSXV:EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019
VANCOUVER and HOUSTON, Dec. 19, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX, TSXV:EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update a.....»»
Pfizer stock ticks higher on new FDA approval for prostate cancer drug
Pfizer Inc. .....»»
Hepion Rips Higher After NASH Drug Confirms Antifibrotic Activity In Animal Study
Shares of Hepion Pharmaceutical.....»»
Why This Is a Huge Win Against Prostate Cancer
Myovant Sciences shares more than doubled on Tuesday after the firm announced results from its Phase 3 Hero study of relugolix for prostate cancer......»»
Cancer patients are turning to crowdfunding for care — and funerals
UCSF study finds that patients are shouldering the burden of higher cancer care costs......»»
ViewRay prostate cancer study findings "highly compelling," says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
VANCOUVER and HOUSTON, Aug. 14, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a c.....»»
Neon Therapeutics Shares Higher After Positive Cancer Vaccine Study
Neon Therapeutics (NASDAQ: NTGN) shares are trading higher after the company announced its personal neoantigen vaccine study demonstrated pr read more.....»»
Study links toxic Sept. 11 dust to prostate cancer
New York would adopt the nation's most aggressive carbon emission reduction goals and give new rights to farmworkers under proposals that were moving through the state Legislature Wednesday. With... To view the full story, click the title link......»»
Why Array BioPharma Shares Fell Thursday
Pharmaceutical company Array BioPharma Inc. (NASDAQ: ARRY) shares dipped more than 3 percent Thursday following comments from a sell-side analyst that investors may have to wait longer for results from Array's BeaconCRC colon cancer study. read more.....»»
Lung Cancer Rates Are Higher in Women Than Men for the First Time Ever. Scientists Don’t Know Why
They do have at least one hypothesis. For the first time, women are more likely to get lung cancer than men. That's according to a new study by the American Ca.....»»
A common ingredient in toothpaste may lead to higher rates of cancer and inflammation, according to a new study
Toothpaste is one of many household products we use daily that containes the antimicrobial chemical triclosan. A recent study suggests that this chemical may aggravate inflammation in .....»»
Toxic Chemicals Found in Tap Water Could Cause Cancer and Developmental Delays, Report Says
The study showed that the EPA’s advisory level of 70 parts per trillion is seven to 10 times higher than what is safe for human exposure......»»